Semin Thromb Hemost 2006; 32: 039-042
DOI: 10.1055/s-2006-946914
Copyright © 2006 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

The Next Generation of Hemophilia Treatment Specialists

Erik Berntorp1 , Edward Gomperts2 , Keith Hoots3 , Wing-Yen Wong2
  • 1Malmö University Hospital, Department of Coagulation Disorders, Malmö, Sweden
  • 2Childrens Hospital Los Angeles, Los Angeles, California
  • 3University of Texas Houston Health Science Center, Houston, Texas
Further Information

Publication History

Publication Date:
21 November 2006 (online)


We currently are witnessing a serious attrition of physicians specializing in hemophilia treatment in Europe and the United States while most physicians who complete training in hematology-oncology choose oncology practice as their career. Nevertheless, recent therapeutic developments, including advances in prophylaxis and inhibitor management, have renewed the demand for experts in hemophilia and related disorders. To meet this demand, several specialty training programs have been developed in the United States and Europe, specifically the International Course in Hemophilia in Malmö, Sweden, the Children's Hospital of Los Angeles International Pediatric Hemostasis and Thrombosis Program, and the Baxter/National Hemophilia Foundation Fellowship Programs. The purpose of these programs is to enhance the clinical expertise and further the professional development of individuals dedicated to treating patients with coagulation disorders.


Erik BerntorpM.D. 

Dept. of Coagulation Disorders, Malmö University Hospital

Malmö, Sweden, SE-20502